BIOMERICA INC Reiterates Going Concern Warning Amidst Deepening Losses, Revenue Decline, and CFO Resignation

summarizeSummary

Biomerica Inc. reported continued financial distress with declining revenue, a quarterly gross loss, and reiterated its going concern warning, further complicated by the CFO's resignation and ongoing reliance on dilutive financing.

check_boxKey Events

• Going Concern Warning Reiterated

  The company explicitly stated that its existing cash and cash equivalents are insufficient to fund operations for the next twelve months, raising substantial doubt about its ability to continue as a going concern. This follows a similar warning issued in the previous 10-Q on 2026-01-14.

• Significant Revenue Decline

  Net sales decreased by 12% to $987,000 for the three months ended February 28, 2026, compared to $1,119,000 in the prior year. For the nine-month period, net sales fell 22% to $3,578,000 from $4,562,000, primarily due to lower contract manufacturing and reduced international distributor activity.

• Quarterly Gross Loss Reported

  The company reported a gross loss of $(44,000) for the three months ended February 28, 2026, a significant deterioration from a gross profit of $19,000 in the same period last year. Year-to-date gross profit also declined from $742,000 to $433,000.

• CFO Resignation

  Gary Lu notified the Board of his decision to resign as Chief Financial Officer, effective April 14, 2026. The company stated his resignation was not due to any disagreement.

auto_awesomeAnalysis

Biomerica Inc. continues to face severe financial challenges, reiterating its 'going concern' warning as cash and working capital are deemed insufficient to fund operations for the next twelve months. The company reported a significant 22% year-over-year decline in net sales for the nine months ended February 28, 2026, and a concerning shift to a gross loss in the most recent quarter. While a one-time $1.1 million Employee Retention Credit temporarily boosted other income for the nine-month period, it masks the underlying operational deterioration. The company remains reliant on dilutive At-The-Market (ATM) offerings for liquidity, having raised $1.455 million in net proceeds during the period. The resignation of CFO Gary Lu adds further uncertainty during this critical period of financial distress and slow new product commercialization.